文献速递胃肠外科围术期管理与 ERAS

吲哚菁绿联合红外或荧光成像用于胃癌前哨淋巴结活检的诊断评估:系统综述与Meta分析

Diagnostic evaluation of sentinel lymph node biopsy using indocyanine green and infrared or fluorescent imaging in gastric cancer: a systematic review and meta-analysis.
PubMed 文献 · Surg Endosc · 2018-02-26

该系统综述与Meta分析纳入10项研究共643例胃癌患者(79.8%为T1肿瘤),评估吲哚菁绿(ICG)联合红外电子内镜(IREE)或近红外荧光成像(NIFI)行前哨淋巴结导航手术的诊断效能。汇总识别率0.99、诊断比值比380.0、灵敏度0.87、特异度1.00,汇总ROC曲线下面积准确度98.3%,但研究间存在异质性,结论需谨慎解读。

要点

  • ICG联合IREE/NIFI对胃癌前哨淋巴结识别率高、特异度好,但灵敏度欠佳。
  • 亚组分析提示低风险QUADAS-2评分、2010年后发表及黏膜下注射的研究诊断性能更优。
  • IREE在诊断比值比、灵敏度和识别率方面优于NIFI。

核心结论

  • ICG联合IREE或NIFI用于胃癌前哨淋巴结导航手术的诊断准确度、诊断比值比和特异度结果令人鼓舞。
  • 灵敏度未达最佳,可能需通过严格的操作方案加以改善。
  • 鉴于研究数量及异质性,结果须谨慎看待。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、SCOPUS、Web of Science和Cochrane Library至2017年5月。
  • 纳入标准为诊断准确性研究设计、肿瘤部位注射ICG、术中使用IREE或NIFI可视化。
  • 共筛选327篇标题或摘要,最终纳入10篇全文研究,共643例患者。
  • 使用QUADAS-2工具评估纳入研究质量。

主要发现

  • 643例患者中多数(79.8%)为T1肿瘤。
  • ICG联合IREE/NIFI的汇总ROC曲线显示测试准确度为98.3%。

临床怎么用

  • ICG联合IREE或NIFI可作为胃癌前哨淋巴结导航手术的术中示踪方法,识别率高且特异度好。
  • 需注意灵敏度有限,应结合严格的操作方案(如黏膜下注射)以提高检出。
  • IREE在诊断性能上可能优于NIFI,条件允许时可优先考虑。

局限性

  • 纳入研究数量有限(10项)。
  • 研究间存在异质性(I2从<25%到>75%)。
  • 灵敏度未达最佳,可能受操作技术影响。
  • 结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sentinel node navigation surgery (SNNS) for gastric cancer using infrared visualization of indocyanine green (ICG) is intriguing because it may limit operative morbidity. We are the first to systematically review and perform meta-analysis on the diagnostic utility of ICG and infrared electronic endoscopy (IREE) or near infrared fluorescent imaging (NIFI) for SNNS exclusively in gastric cancer. METHODS: A search of electronic databases MEDLINE, EMBASE, SCOPUS, Web of Science, and the Cochrane Library using search terms "gastric/stomach" AND "tumor/carcinoma/cancer/neoplasm/adenocarcinoma/malignancy" AND "indocyanine green" was completed in May 2017. Articles were selected by two independent reviewers based on the following major inclusion criteria: (1) diagnostic accuracy study design; (2) indocyanine green was injected at tumor site; (3) IREE or NIFI was used for intraoperative visualization. 327 titles or abstracts were screened. The quality of included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2. RESULTS: Ten full text studies were selected. 643 patients were identified with the majority of patients possessing T1 tumors (79.8%). Pooled identification rate, diagnostic odds ratio, sensitivity, and specificity were 0.99 (0.97-1.0), 380.0 (68.71-2101), 0.87 (0.80-0.93), and 1.00 (0.99-1.00), respectively. The summary receiver operator characteristic for ICG + IREE/NIFI demonstrated a test accuracy of 98.3%. Subgroup analysis found improved test performance for studies with low-risk QUADAS-2 scores, studies published after 2010 and submucosal ICG injection. IREE had improved diagnostic odds ratio, sensitivity, and identification rate compared to NIFI. Heterogeneity among studies ranged from low (I2 < 25%) to high (I2 > 75%). CONCLUSIONS: We found encouraging results regarding the accuracy, diagnostic odds ratio, and specificity of the test. The sensitivity was not optimal but may be improved by a strict protocol to augment the technique. Given the number and heterogeneity of studies, our results must be viewed with caution.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Skubleny D, Dang JT, Skulsky S, et al. Diagnostic evaluation of sentinel lymph node biopsy using indocyanine green and infrared or fluorescent imaging in gastric cancer: a systematic review and meta-analysis. Surg Endosc. 2018. PMID: 29484554. doi:10.1007/s00464-018-6100-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。